Dan Zandberg

This study looked at 161 people with advanced solid tumors (like lung, bladder, skin, and kidney cancers) who had already been on immunotherapy (PD-1/PD-L1 inhibitors) for one year and whose disease was stable. Half stopped treatment, and half continued. The goal was to see if st…